The BCL-2 inhibitors market represents a significant segment within the global oncology landscape, driven by the urgent need for innovative therapies targeting cancer cells. These inhibitors play a crucial role in the treatment of various hematologic malignancies and solid tumors by targeting the BCL-2 protein, which helps cancer cells evade apoptosis. Gain valuable insights with our latest...